Skip to main content
Top

Discover Oncology

Issue 1-2/2012

Content (7 Articles)

Editorial

Hormones and Cancer: a Bright Future

Carol A. Lange

Mechanisms of HGF/Met Signaling to Brk and Sam68 in Breast Cancer Progression

Alessia Locatelli, Kristopher A. Lofgren, Andrea R. Daniel, Nancy E. Castro, Carol A. Lange

Estrogen Receptor-beta Mediates the Protective Effects of Aromatase Induction in the MMTV-Her-2/neu x Aromatase Double Transgenic Mice

Hareesh B. Nair, Rao P. Perla, Nameer B. Kirma, Naveen K. Krishnegowda, Manonmani Ganapathy, Rajib Rajhans, Sujit S. Nair, Pothana Saikumar, Ratna K. Vadlamudi, Rajeshwar Rao Tekmal

Functional Characterization of a Genetic Polymorphism in the Promoter of the ESR2 Gene

Santosh Philips, Alexandra Richter, Steffi Oesterreich, James M. Rae, David A. Flockhart, Narayanan B. Perumal, Todd C. Skaar

Frequent Germ-Line Mutations of the MEN1, CASR, and HRPT2/CDC73 Genes in Young Patients with Clinically Non-familial Primary Hyperparathyroidism

Lee F. Starker, Tobias Åkerström, William D. Long, Alberto Delgado-Verdugo, Patricia Donovan, Robert Udelsman, Richard P. Lifton, Tobias Carling

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine